#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2330333	ADME	Metabolic stability in Sprague-Dawley rat kidney homogenate	Rattus norvegicus	2	ALA2321797	tissue-based format	Scientific Literature
2.	ALA2330334	ADME	Metabolic stability in Sprague-Dawley rat liver homogenate	Rattus norvegicus	2	ALA2321797	tissue-based format	Scientific Literature
3.	ALA2330335	ADME	Half life in Sprague-Dawley rat at 10 mg/kg, iv by LC-MS/MS analysis	Rattus norvegicus	2	ALA2321797	organism-based format	Scientific Literature
4.	ALA2330336	Physicochemical	Chemical stability of the compound in PBS after 1 hr by HPLC analysis in presence of proteinase K		3	ALA2321797	small-molecule physicochemical format	Scientific Literature
5.	ALA2330337	Functional	Antiviral activity against T20-resistant Human immunodeficiency virus 1 NL4-3 harboring gp41 NHR (36G)V38A/N42T mutation infected in human MT2 cells assessed as inhibition of p24 production measured 4 days post infection by ELISA relative to T20-sensitive HIV1 NL4-3 gp41 NHR D36G mutant	Human immunodeficiency virus 1	4	ALA2321797	organism-based format	Scientific Literature
6.	ALA2330338	Functional	Antiviral activity against T20-resistant Human immunodeficiency virus 1 NL4-3 harboring gp41 NHR (36G)V38E/N42S mutation infected in human MT2 cells assessed as inhibition of p24 production measured 4 days post infection by ELISA relative to T20-sensitive HIV1 NL4-3 gp41 NHR D36G mutant	Human immunodeficiency virus 1	4	ALA2321797	organism-based format	Scientific Literature
7.	ALA2330339	Functional	Antiviral activity against T20-resistant Human immunodeficiency virus 1 NL4-3 harboring gp41 NHR (36G)N42T/N43K mutation infected in human MT2 cells assessed as inhibition of p24 production measured 4 days post infection by ELISA relative to T20-sensitive HIV1 NL4-3 gp41 NHR D36G mutant	Human immunodeficiency virus 1	4	ALA2321797	organism-based format	Scientific Literature
8.	ALA2330340	Functional	Antiviral activity against T20-resistant Human immunodeficiency virus 1 NL4-3 harboring gp41 NHR (36G)V38A/N42D mutation infected in human MT2 cells assessed as inhibition of p24 production measured 4 days post infection by ELISA relative to T20-sensitive HIV1 NL4-3 gp41 NHR D36G mutant	Human immunodeficiency virus 1	4	ALA2321797	organism-based format	Scientific Literature
9.	ALA2330341	Functional	Antiviral activity against T20-resistant Human immunodeficiency virus 1 NL4-3 harboring gp41 NHR (36G)V38A mutation infected in human MT2 cells assessed as inhibition of p24 production measured 4 days post infection by ELISA relative to T20-sensitive HIV1 NL4-3 gp41 NHR D36G mutant	Human immunodeficiency virus 1	4	ALA2321797	organism-based format	Scientific Literature
10.	ALA2330342	Functional	Antiviral activity against T20-resistant Human immunodeficiency virus 1 NL4-3 harboring gp41 NHR (36G)V38A/N42T mutation infected in human MT2 cells assessed as inhibition of p24 production measured 4 days post infection by ELISA	Human immunodeficiency virus 1	4	ALA2321797	organism-based format	Scientific Literature
11.	ALA2330343	Functional	Antiviral activity against T20-resistant Human immunodeficiency virus 1 NL4-3 harboring gp41 NHR (36G)V38E/N42S mutation infected in human MT2 cells assessed as inhibition of p24 production measured 4 days post infection by ELISA	Human immunodeficiency virus 1	4	ALA2321797	organism-based format	Scientific Literature
12.	ALA2330344	Functional	Antiviral activity against T20-resistant Human immunodeficiency virus 1 NL4-3 harboring gp41 NHR (36G)N42T/N43K mutation infected in human MT2 cells assessed as inhibition of p24 production measured 4 days post infection by ELISA	Human immunodeficiency virus 1	4	ALA2321797	organism-based format	Scientific Literature
13.	ALA2330345	Functional	Antiviral activity against T20-resistant Human immunodeficiency virus 1 NL4-3 harboring gp41 NHR (36G)V38A/N42D mutation infected in human MT2 cells assessed as inhibition of p24 production measured 4 days post infection by ELISA	Human immunodeficiency virus 1	4	ALA2321797	organism-based format	Scientific Literature
14.	ALA2330346	Functional	Antiviral activity against T20-resistant Human immunodeficiency virus 1 NL4-3 harboring gp41 NHR (36G)V38A mutation infected in human MT2 cells assessed as inhibition of p24 production measured 4 days post infection by ELISA	Human immunodeficiency virus 1	4	ALA2321797	organism-based format	Scientific Literature
15.	ALA2330347	Binding	Binding affinity to HIV1 Envelope glycoprotein gp41 NHR N36 peptide after 30 mins by size-exclusion HPLC analysis	Human immunodeficiency virus 1	5	ALA2321797	assay format	Scientific Literature
16.	ALA2330348	Binding	Inhibition of HIV1 Envelope glycoprotein gp41 Fe(env2.0)3-mediated 6HB formation using CP2-LY as probe by FRET assay	Human immunodeficiency virus 1	4	ALA2321797	assay format	Scientific Literature
17.	ALA2330349	Functional	Antiviral activity against T20-sensitive Human immunodeficiency virus 1 NL4-3 harboring gp41 NHR D36G mutation infected in human MT2 cells assessed as inhibition of p24 production measured 4 days post infection by ELISA	Human immunodeficiency virus 1	4	ALA2321797	organism-based format	Scientific Literature
18.	ALA2330350	Toxicity	Selectivity index, ratio of CC50 for human TZM-b1 cells to EC50 for Human immunodeficiency virus 1 3B		4	ALA2321797	cell-based format	Scientific Literature
19.	ALA2330351	ADME	Cytotoxicity against human TZM-b1 cells after 24 hrs by MTS assay	Homo sapiens	4	ALA2321797	cell-based format	Scientific Literature
20.	ALA2330352	Functional	Antiviral activity against Human immunodeficiency virus 1 3B infected in human MT2 cells assessed as inhibition of p24 production measured 4 days post infection by ELISA	Human immunodeficiency virus 1	5	ALA2321797	organism-based format	Scientific Literature